Results 221 to 230 of about 3,047,347 (315)

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

open access: yesArthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Socioeconomic disparities in adult mortality in Latin America. [PDF]

open access: yesBMJ Glob Health
Buitrago G   +5 more
europepmc   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Impronta de la Revista Medicina y Cine en la América de habla hispana

open access: yesRevista de Medicina y Cine / Journal of Medicine and Movies, 2016
Alberto Enrique D’OTTAVIO
doaj  

The global macroeconomic burden of diabetes mellitus. [PDF]

open access: yesNat Med
Chen S   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy